1 / 5

Microfluidic qRT-PCR (Applied Biosystems): included 93 apoptotic genes; 384 well plate

Supplemental Table 1 . Details of handling and experimental usage of CLL lymphocytes obtained from patients . Microfluidic qRT-PCR (Applied Biosystems): included 93 apoptotic genes; 384 well plate Real-time RT-PCR : Real-time reverse-phase polymerase chain reaction

eugenem
Download Presentation

Microfluidic qRT-PCR (Applied Biosystems): included 93 apoptotic genes; 384 well plate

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplemental Table 1. Details of handling and experimental usage of CLL lymphocytes obtained from patients Microfluidic qRT-PCR (Applied Biosystems): included 93 apoptotic genes; 384 well plate Real-time RT-PCR : Real-time reverse-phase polymerase chain reaction RPPA: Reverse Phase Protein Array

  2. Supplemental Table 2. Cytogenetics and prognostic markers of patient samples used for RPPA, immunoblot analyses. NA: Information not available; PR: Partial response; SD: Stable disease; PROG: Progressive disease; M: Mutated; UM: Unmutated

  3. Supplemental Table 3. List of ligands, reagents and antibodies along with their sources

  4. Supplemental Table 4. Transcript and protein expressions of Bcl-2 family members measured through different techniques. *Unpaired student t-test; ND, below limit of detection; NA, not applicable (not in the assay)

  5. Supplemental Table 5. Combination of duvelisib and venetoclax: Expected % apoptosis vs Observed % apoptosis . Red: Expected % apoptosis < Observed % apoptosis indicates either additive or synergistic combination. Green: Expected % apoptosis > Observed % apoptosis indicates either non-additive, non-synergistic or antagonistic combination. Method of calculating Expected % apoptosis: 1) Raw viability was normalized to "% viability”. 2) Expected % viability was calculated using following formula: “ % viability of drug A * % viability of drug B / 100” . 3) Expected % apoptosis was calculated as "100-(Expected % apoptosis)"

More Related